Clinical Trial Update: A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1, two-part single ascending dose study evaluated the safety, tolerability, and pharmacokinetics of intravenous rolapitant in healthy volunteers and has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Rolapitant (rolapitant)

Snippet

Sponsor: Tesaro, Inc. | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 1 | Status: COMPLETED